Profesyonel çevirmenler, işletmeler, web sayfaları ve erişimin serbest olduğu çeviri havuzlarından.
(ipk)
(ilp)
Son Güncelleme: 2012-04-12
Kullanım Sıklığı: 2
Kalite:
farmakokinetika v ipk
pharmacokinetics in ilp
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite:
kontraindikácie pre procedúru ipk:
contraindications to the ilp procedure:
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 3
Kalite:
beromun sa má podávať miernou hypertermickou ipk.
beromun should be administered by mild hyperthermic ilp.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite:
prosím, pred procedúrou ipk si pozrite spc melfalanu.
please refer to the spc of melphalan prior to commencing an ilp procedure.
Son Güncelleme: 2012-04-12
Kullanım Sıklığı: 2
Kalite:
zvyčajne sa druhá dávka beromunu prostredníctvom ipk nepodáva.
you will usually not receive a second ilp with beromun.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite:
potom sa pridá melfalan a ipk pokračuje ďalších 60 minút.
after that, melphalan will be added and the ilp continued for another 60 minutes.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite:
preto musia byť pacienti počas prvých 3 dní po ipk sledovaní.
therefore patients should be monitored during the first three days after the ilp.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 3
Kalite:
počas ipk sa dôrazne odporúča monitorovanie tlaku v centrálnych žilách a tepnách.
during the ilp, central venous pressure and arterial pressure monitoring is strongly recommended.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 3
Kalite:
počas ipk a v bezprostrednom pooperačnom období sa zvyčajne robí množstvo terapeutických opatrení.
a number of therapeutic measures are routinely used during the ilp and in the immediate post-operative period.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 3
Kalite:
v prípade potreby sa môže druhá ipk zrealizovať 6-8 týždňov po prvej ipk.
when necessary a second ilp can be considered 6-8 weeks after the first ilp.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 3
Kalite:
po ipk má vždy nasledovať štandardná vymývacia procedúra s použitím intravenóznej infúzie dextranu 70 alebo podobnej tekutiny.
following the ilp, a standard wash-out procedure should always be employed, using dextran 70 intravenous infusion or similar fluid.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 3
Kalite:
ak sa to však stane, lekár na odstránenie beromunu okamžite vymyje postihnutú končatinu vhodným roztokom a ipk skončí.
however, should this occur, your doctor will immediately wash out your affected limb to remove beromun, and the ilp will be stopped.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite:
nežiaduce účinky môžu byť spojené s beromunom, melfalanom alebo procedúrou ipk a so súvisiacimi opatreniami alebo s kombináciou týchto faktorov.
undesirable effects may be related to beromun, to melphalan, or to the ilp procedure and associated measures, or to a combination of these factors.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite:
na monitorovanie tlaku v pľúcnych artériách a klinového tlaku počas ipk a v pooperačnom období sa môže použiť swan-ganzov katéter.
a swan-ganz catheter may be considered for monitoring pulmonary artery pressure and wedge pressure during the ilp and in the post-operative period.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 3
Kalite:
beromun sa podáva technikou izolovanej perfúzie končatiny (ipk), spolu s protinádorovým liečivom melfalanom.
beromun will be administered by isolated limb perfusion (ilp), together with the anti-tumour agent melphalan.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite:
maximálna tolerovaná dávka (mtd) tasonermínu pre ipk je 4 mg, čo je 10-násobok systémovej mtd.
the maximum tolerated dose (mtd) of tasonermin for ilp is 4 mg, which is 10 times the systemic mtd.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite:
párové analýzy prežitia pacientov liečených ipk beromunom a melfalanom v porovnaní s historickou kontrolou nepreukázali nejaký rozdiel v prežití (p=0,5).
a matched-pair survival analysis of patients treated by beromun and melphalan ilp as compared to a historical control failed to demonstrate any survival difference (p=0.5).
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite: